Notice NOT-DC-23-004 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: MGnify is EMBL-EBI’s microbiome sequence data analysis resource, which performs the archiving, assembly and analysis of metagenomics data. As the nu Hinxton, Cambridgeshire, England

Notice NOT-CA-23-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-23-116 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) focuses on understanding bidirectional relationships between social media use and adolescent mental health, psychiatric symptoms, and risk or resilience for psychopathology. For the purposes of this FOA, social media are defined as internet-based communication platforms and applications that enable interactions between users by sharing or consuming information. The FOA focuses on adolescents (broadly defined here as 10-20 years of age), who have increasing access to social media and greater autonomy in their use of digital platforms. No effectiveness/efficacy trials will be accepted.

Funding Opportunity RFA-MH-23-115 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) focuses on understanding bidirectional relationships between social media use and adolescent mental health, psychiatric symptoms, and risk or resilience for psychopathology. For the purposes of this FOA, social media are defined as internet-based communication platforms and applications that enable interactions between users by sharing or consuming information. The FOA focuses on adolescents (broadly defined here as 10-20 years of age), who have increasing access to social media and greater autonomy in their use of digital platforms. No effectiveness/efficacy trials will be accepted.

Notice NOT-AR-23-008 from the NIH Guide for Grants and Contracts

Competitive Salary: F. Hoffmann-La Roche AG: The PositionRoche Pharma Research and Early Development (pRED), an industry leader in pushing the boundaries of the sciences in drug development, is c United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionScientist 3, Cell and Tissue Genomics, Cancer BiologyGenentechs Department of Cell and Tissue Genomics is seeking a creative and curiosity San Francisco, California (US)

Funding Opportunity PAR-23-049 from the NIH Guide for Grants and Contracts. NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators , and share findings, data and their resources, consistent with achieving the goals of the program.

Notice NOT-OD-23-051 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-052 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-016 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-068 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health, is a limited competition FOA encouraging a resource project (R28) application from a center currently supported under an existing grant, entitled Brain Tissue Resource Center for Alcohol Research to (i) develop a bank of brain tissues (fresh-frozen and formalin-fixed) from alcoholic and control cases with confirmed clinical and pathological diagnoses, (ii) develop and promote a prospective brain donor program in Australia (Using our Brains) to enhance the brain bank, (iii) establish an associated DNA (blood) bank from the brain donor group, and (iv) invite research groups with an interest in alcohol-related brain damage to submit applications for studies using these tissues.

Funding Opportunity RFA-AR-24-002 from the NIH Guide for Grants and Contracts. NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed)

Funding Opportunity RFA-AR-24-001 from the NIH Guide for Grants and Contracts. NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)

Notice NOT-NS-23-056 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-029 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-TR-23-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to establish Centers to support research that will accelerate the translational use of Microphysiological Systems (MPS) in drug development through regulatory acceptance and adoption for industrial use, by establishing MPS that are fit-for-purpose for industry needs and have specific defined contexts of use (CoUs) and will be developed with consideration of applicable expectations to achieve regulatory approval. For this FOA, the term drugs refers to both human pharmacological and biological products unless otherwise specified. These Centers will further the development of MPS as drug development tools (DDTs) that, once qualified, will be made publicly and commercially available to fill unmet needs in drug development.

Notice NOT-NS-23-043 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-028 from the NIH Guide for Grants and Contracts